Expression, Localization and Prognosis Association of MEP50 in Breast Cancer

SIMPLE SUMMARY: The arginine methyltransferase PRMT5 is an emerging therapeutic target for various cancers including breast cancer. In this study, we examine the expression and subcellular localization of its main cofactor, MEP50, in the different breast cancer subgroups. High levels of MEP50 are fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Samyuktha, Vinet, Mathilde, Dakroub, Rayan, Lesage, Laetitia, Ye, Mengliang, Fayyad-Kazan, Hussein, Nicolas, André, Meseure, Didier, Dubois, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563057/
https://www.ncbi.nlm.nih.gov/pubmed/36230689
http://dx.doi.org/10.3390/cancers14194766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563057/
https://www.ncbi.nlm.nih.gov/pubmed/36230689
http://dx.doi.org/10.3390/cancers14194766

Ejemplares similares